Fortrea Holdings (FRA:K67) Additional Paid-In Capital : €1,843 Mil(As of Mar. 2024)

View and export this data going back to 2023. Start your Free Trial

What is Fortrea Holdings Additional Paid-In Capital?

Fortrea Holdings's quarterly additional paid-in capital declined from Sep. 2023 (€1,862 Mil) to Dec. 2023 (€1,840 Mil) but then increased from Dec. 2023 (€1,840 Mil) to Mar. 2024 (€1,843 Mil).

Fortrea Holdings's annual additional paid-in capital stayed the same from Dec. 2021 (€0 Mil) to Dec. 2022 (€0 Mil) but then increased from Dec. 2022 (€0 Mil) to Dec. 2023 (€1,840 Mil).

Fortrea Holdings Additional Paid-In Capital Historical Data

The historical data trend for Fortrea Holdings's Additional Paid-In Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Fortrea Holdings Additional Paid-In Capital Chart

Fortrea Holdings Annual Data

Trend

Dec20

Dec21

Dec22

Dec23

Additional Paid-In Capital

1,839.69

Fortrea Holdings Quarterly Data
	Dec20	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Additional Paid-In Capital	Get a 7-Day Free Trial						1,926.38	1,824.31	1,862.38	1,839.69	1,842.67

Fortrea Holdings Additional Paid-In Capital Calculation

Capital that a company raises in a financing round in excess of the capital's par value. The account represents the excess paid by an investor over the par-value price of a stock issue. Additional paid-in-capital can arise from issuing either preferred or common stock.

Additional Paid-In Capital is calculated as

Additional Paid-In Capital

(Issue Price

Par Value)

Shares Outstanding (Diluted Average)

Fortrea Holdings Additional Paid-In Capital Related Terms

Thank you for viewing the detailed overview of Fortrea Holdings's Additional Paid-In Capital provided by GuruFocus.com. Please click on the following links to see related term pages.

Fortrea Holdings (FRA:K67) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Fortrea Holdings Inc (FRA:K67) » Definitions » Additional Paid-In Capital

Comparable Companies

Traded in Other Exchanges

FTRE:USA

Address

8 Moore Drive, Durham, NC, USA, 27709

Website

https://www.fortrea.com

Fortrea Holdings is a late-stage contract research organization, or CRO, that provides comprehensive Phase I through IV clinical trial management, clinical pharmacology, and patient access solutions. The company works with emerging and large biopharma, medical device, and diagnostic companies to run their clinical trials as a functional-service provider, full-service provider, and offers hybrid trials. In 2023, Fortrea was formed as an independent, publicly traded company after LabCorp spun off its clinical development business, which it acquired via its purchase of Covance in 2015 for $6.1 billion. Fortrea has 19,000 staff members across 90 countries.

Fortrea Holdings (FRA:K67) Headlines

No Headlines